NLM Logo

dabrafenib MeSH Supplementary Concept Data 2022


MeSH Supplementary
dabrafenib
Unique ID
C561627
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C561627
Entry Term(s)
GSK 2118436
GSK-2118436
GSK2118436
Pharm Action
Antineoplastic Agents
Protein Kinase Inhibitors
Registry Number
QGP4HA4G1B
Heading Mapped to
*Imidazoles
*Oximes
Frequency
710
Note
an antineoplastic agent that inhibits BRAF kinase; InChIKey: BFSMGDJOXZAERB-UHFFFAOYSA-N
Source
Arch Pharm Res 2011 May;34(5):699-701
Indexing Information
Proto-Oncogene Proteins B-raf
Date of Entry
2011/10/09
Revision Date
2014/01/14
dabrafenib Preferred
GSK 2118436 Narrower
page delivered in 0.004s